We are live on
!
Find out more
SC
Sophrosyne Capital Portfolio holdings
AUM
$11.5M
1-Year Est. Return
17.82%
This Fund
S&P 500
This Quarter
Est. Return
+16.88%
1 Year Est. Return
+17.82%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$64.8M
AUM Growth
-$19.9M
(-23%)
Cap. Flow
-$24.5M
Cap. Flow
% of AUM
-37.79%
Top 10 Holdings %
Top 10 Hldgs %
64.49%
Holding
63
New
5
Increased
6
Reduced
22
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CYNO
Cynosure, Inc. Class A
CYNO
|
+$576K |
| 2 |
IPHI
INPHI CORPORATION
IPHI
|
+$541K |
| 3 |
RTK
Rentech, Inc.
RTK
|
+$444K |
| 4 |
CEMI
Chembio diagnostics, Inc.
CEMI
|
+$428K |
| 5 |
Research Frontiers
REFR
|
+$413K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ZLTQ
ZELTIQ Aesthetics, Inc.
ZLTQ
|
+$5M |
| 2 |
Strategy Inc
MSTR
|
+$2.79M |
| 3 |
Arcturus Therapeutics
ARCT
|
+$2.47M |
| 4 |
FLNA
Filana Therapeutics
FLNA
|
+$2.27M |
| 5 |
DRRX
DURECT Corp
DRRX
|
+$1.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 50% |
| 2 | Technology | 18.71% |
| 3 | Utilities | 9.18% |
| 4 | Communication Services | 7.12% |
| 5 | Financials | 5.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Scully Royalty
SRL
$88.9M
| – | – |
-42,700
| Closed | -$1.52M |
|
|
WPRT
52
Westport Fuel Systems
WPRT
$35.1M
| – | – |
-830
| Closed | -$87K |
|
53
Xylem
XYL
$26.3B
| – | – |
-1,600
| Closed | -$57K |
|
|
CUTR
54
DELISTED
Cutera, Inc.
CUTR
| – | – |
-94,700
| Closed | -$958K |
|
|
MNDT
55
DELISTED
Mandiant, Inc. Common Stock
MNDT
| – | – |
-18,000
| Closed | -$550K |
|
|
SRCI
56
DELISTED
SRC Energy Inc
SRCI
| – | – |
-9,800
| Closed | -$119K |
|
|
LAYN
57
DELISTED
Layne Christensen Co
LAYN
| – | – |
-10,500
| Closed | -$102K |
|
|
ELOS
58
DELISTED
Syneron Medical Ltd
ELOS
| – | – |
-71,300
| Closed | -$713K |
|
|
ELNK
59
DELISTED
EarthLink Holdings Corp.
ELNK
| – | – |
-99,700
| Closed | -$340K |
|
|
MWV
60
DELISTED
MEADWESTVACO CORP
MWV
| – | – |
-3,700
| Closed | -$151K |
|
|
KFX
61
DELISTED
KOFAX LIMITED COM STK
KFX
| – | – |
-160,400
| Closed | -$1.24M |
|
|
RKUS
62
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
| – | – |
-11,500
| Closed | -$154K |
|
Similar funds
SFM
IACGFA
LS
NGPI
AP
GRP
NVPV
AC
Sophrosyne Capital's Q4 2014 Portfolio in Review
As of Q4 2014, Sophrosyne Capital held 63 positions worth $64.8M, down 23% from $84.7M the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Sophrosyne Capital withdrew a net $24.5M in Q4 2014, closing 23 positions and reducing 22 holdings. Its most notable exit was Arcturus Therapeutics, an estimated $2.47M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 50% of assets, up from 44% a quarter earlier, followed by Technology and Utilities.
Against the trend, Sophrosyne Capital opened a new position in Chembio diagnostics, Inc. worth $407K.
- Sophrosyne Capital's largest Q4 2014 buy was Chembio diagnostics, Inc.: 103,400 shares worth $407K.
- Sophrosyne Capital added most to Cynosure, Inc. Class A in Q4 2014, an estimated $576K increase.
- Sophrosyne Capital's biggest Q4 2014 reduction was ZELTIQ Aesthetics, Inc., cutting an estimated $5M.
- Sophrosyne Capital fully exited Arcturus Therapeutics in Q4 2014, selling an estimated $2.47M.
- Sophrosyne Capital's ten largest holdings make up 64% of its $64.8M portfolio in Q4 2014.
- Sophrosyne Capital opened 5 new positions and closed 23 in Q4 2014.
- Sophrosyne Capital's portfolio value fell 23% quarter-over-quarter to $64.8M.
Based on Sophrosyne Capital's 13F filing for Q4 2014, filed 26 Jan 2015.